fda warning letters glp-1 october 2025 news Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly GLP-1 Weight-Loss Drug Demonstration Begins

Key metrics to monitor include body weight trends over weeks rather than daily fluctuations, subjective appetite ratings before and after meals, frequency and intensity of cravings throughout the day, energy levels and any changes in fatigue patterns, and digestive symptoms that might indicate the supplement or medication is affecting gut function

Its the internal conversation that happens before you ever pick up a fork

SAN DIEGO-Bariatric surgery far outperforms lifestyle interventions and glucagon-like peptide-1 (GLP-1) medications at maintaining weight loss, according to a meta-analysis presented at the 2024 annual meeting of the American Society for Metabolic and Bariatric Surgery

Focus on compliance, value, and scalability to ensure a successful product launch

Weight loss injections mimic the effects of GLP-1, supporting you to lose weight if you are obese or overweight [2], but what if you could promote its release in a more natural way

However, these benefits may never come to fruition if GLP-1 RAs induce dietary modifications that create maladaptive gut microbiome shifts, especially over the long term